Pfizer/BioNTech COVID-19 vaccine shows 90.7% efficacy in trial in children

Posted on AllSides October 22nd, 2021
From The Center

The Pfizer (PFE.N)/BioNTech COVID-19 vaccine showed 90.7% efficacy against the coronavirus in a clinical trial of children 5 to 11 years old, the U.S. drugmaker said on Friday.

Read full story

Reuters

AllSides Media Bias Rating: Center
AllSides Media Bias Rating: Center
106710/84317
See full bias rating for Reuters
Learn about media bias
https://www.reuters.com/business/healthcare-pharmaceuticals/pfizerbiontech-covid-19-vaccine-shows-907-efficacy-trial-children-2021-10-22/

More News about Coronavirus from the Left, Center and Right

From the Left

From the Center

From the Right